Corient IA’s Abbott ABT Stock Holding History

Corient IA’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,780	Closed	-$183K	–	250
2026 Q1	$183K	Sell	1,780 -220	-11%	-$24.8K	0.17%	214
2025 Q4	$251K	Hold	2,000	–	–	0.24%	175
2025 Q3	$268K	Sell	2,000 -1,615	-45%	-$212K	0.2%	197
2025 Q2	$492K	Hold	3,615	–	–	0.29%	121
2025 Q1	$480K	Buy	+3,615	New	+$460K	0.34%	111

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Corient IA's ABT Position: Q2 2026 in Review

Corient IA sold out of Abbott (ABT) in Q2 2026, closing a stake of 1,780 shares — an estimated $183K sold.

Corient IA first reported a position in ABT in Q1 2025 and held it in 5 quarters. The position peaked at $492K in Q2 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Corient IA reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Corient IA sold 1,780 Abbott shares in Q2 2026, an estimated $183K.
Corient IA first reported a position in Abbott in Q1 2025 and held it in 5 quarters.
Corient IA's Abbott position peaked at $492K in Q2 2025.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.